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Viral entry into host cells depends upon specific interactions between virus attachment proteins and cell surface receptors
that enable virus binding and internalization of virus and/or the virus–receptor complex. We have recently reported that
the ubiquitous cell surface molecule, decay-accelerating factor (DAF), is a major cell attachment receptor for Coxsackievi-
ruses B1, B3, and B5. However, DAF permits only virus binding and not virus internalization, invoking the presence of
secondary or accessory receptors. Among the known receptors for enteroviruses are members of the cell adhesion molecule
family known as integrins. In the present study, we found that expression of the epithelial-restricted integrin, avb6, on
colonic epithelial cells significantly enhanced Coxsackievirus B1-mediated cell lysis. Importantly, the viral-mediated cell
killing required the presence of the 11-amino-acid C-terminal cytoplasmic extension unique to the b6 subunit, providing the
first evidence of regulation of viral infectivity by integrin cytoplasmic domains. These results indicate that avb6 expression
on intestinal epithelial cells critically affects Coxsackievirus B1 infectivity. This may be essential in the conversion of
asymptomatic enterovirus infection into clinically apparent disease. q 1997 Academic Press
INTRODUCTION entry into cells, thereby implicating accessory or second-
ary receptors (Shafren et al., 1995).
Specific receptors have been identified to date for 17 Among candidate molecules which may serve either
of the known enteroviruses; however, where a single as primary or as secondary receptors are members of
virus receptor has been identified it is likely that second-
the cell adhesion family of receptors called integrins.
ary or accessory receptors are also involved in cell infec-
Individual integrins comprise an a and a b subunit in
tivity (Shafren et al., 1995). For example, in the Coxsackie-
noncovalent association, and there are now known to be
virus group of enteroviruses early studies of receptor
at least 15 a subunits and 8 b subunits that can produceaffinity for Coxsackievirus B3 (CVB3) indicated that at
21 individual receptors (Hynes, 1992). The b1 subfamilyleast two different cell receptors may be involved, in that
defines one group sometimes referred to as VLA (verythe prototype strain Nancy preferentially bound to an
late antigens) in which the b1 chain combines with differ-unidentified 49-kDa cell protein (Mapoles et al., 1985),
ent a chain members. In another subfamily of receptors,while a CVB3 strain adapted to growth in rhabdomyosar-
designated av, the promiscuous av subunit binds to indi-coma cells had an altered specificity and bound to a 60-
vidual and different b subunits which, thereby, determineto 70-kDa cell surface protein (Reagan et al., 1984). In
ligand specificity for an individual receptor (Hynes, 1992).fact, we and others have recently reported that CVB3
Integrins that have been found to act either as a primarystrains that bind the 60- to 70-kDa molecule are using
viral receptor (a2b1 for echovirus 1; avb3 for Coxsackie-decay-accelerating factor (DAF), a 70-kDa glycosylphos-
virus A9) (Bergelson et al., 1993; Roivainen and Piir-phatidylinositol-anchored glycoprotein that protects cells
rainen, 1994) or as a secondary viral receptor (avb3/from complement-mediated lysis (Coyne et al., 1992; Ber-
avb5 for adenovirus 2) (Wickham et al., 1993) also bindgelson et al., 1995; Shafren et al., 1995). DAF is widely
an extensive range of ligands through several knownexpressed on human cells, including the intestinal epi-
peptide motifs (Hynes, 1992).thelium (Koretz et al., 1992). Interestingly, although DAF
Enteroviruses normally replicate in the intestine, andis a major cell attachment receptor for Coxsackieviruses
viremic spread disseminates infection widely to involveB1, B3, and B5, this molecule does not facilitate virus
the central nervous system, the reticuloendothelial sys-
tem, or preferential targets such as skin, skeletal muscle,
and the myocardium. In the present study, we examined1 The first two authors made equal contributions to this article.
2 To whom correspondence and reprint requests should be ad- the role of av integrins in the replication of one member
dressed at Discipline of Surgical Science, Faculty of Medicine and of the Coxsackievirus B group using colon cancer cellsHealth Sciences, David Maddison Clinical Sciences Building, Royal
as a surrogate model for intestinal epithelium. Expres-Newcastle Hospital, NSW 2300 Australia. Fax: 61-02-49236984. E-mail:
magrez@mail.newcastle.edu.au. sion of the integrin avb6 (which binds fibronectin) (Shep-
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pard et al., 1990; Busk et al., 1992) on colon cancer cells ing only the 11-amino-acid extension at the carboxy-ter-
minus unique to the b6 integrin subunit (777t) (Agrez etsignificantly enhanced the ability of Coxsackievirus B1
(CVB1) to mediate cell lysis. Importantly, the viral-medi- al., 1994). Mock transfectants contained vector alone.
ated cell killing required the presence of the 11-amino-
Virus infectivity assayacid C-terminal cytoplasmic extension unique to the b6
subunit, providing the first evidence of regulation of viral LIM1215 and SW480 colon cancer cells were seeded
infectivity by integrin cytoplasmic domains. at a cell density of 105 cells per well in 96-well microtitra-
tion plates (Nunc) and allowed to reach confluence dur-
MATERIALS AND METHODS ing the next 24–48 h. Confluent monolayer cultures were
washed twice with PBS and infected with 100-ml aliquotsCell lines, antibodies, and viruses
of CVB1 in the form of fivefold dilutions of stock virus in
The human colon cancer cell lines SW480 and DMEM/1.0% FCS. Unbound virus was removed by PBS
LIM1215 were obtained from the American Type Culture wash and cells were then incubated in DMEM/10% FCS
Collection (Rockville, MD) and Dr. R. Whitehead, Ludwig at 377C in 5% CO2 for 48 h. To quantitate cell survival,
Institute for Cancer Research, Melbourne, Australia, re- monolayers were incubated with a crystal violet/metha-
spectively, and maintained as monolayers in Dulbecco’s nol solution and washed with distilled water, and the
modified Eagle’s medium (DMEM) supplemented with plates read on a multiscan ELISA plate reader (Flow
4.5 g/L glucose, L-glutamine, 10% fetal calf serum (FCS) Laboratories) at a wavelength of 540 nm. The mean ab-
and penicillin/streptomycin. Monoclonal antibodies sorbance of triplicate wells incubated with virus was ex-
(mAb) L230 and AB3 against av and b3 subunits, respec- pressed as a percentage of the mean absorbance of
tively, were prepared in our laboratory from hybridoma control wells grown in the absence of virus.
cells obtained from the American Type Culture Collec-
tion. Monoclonal antibodies E7P6 and P1F6 against b6 CVB1 growth curves
and b5 subunits, respectively, have been described pre-
Confluent monolayers of SW480 Mock, SW480 b6, andviously (Weinacker et al., 1994). The monoclonal antibody
SW480 777t cells in 24-well plates were inoculated withQE2E5 against the b1 subunit was a gift from Dr. Graeme
CVB1 (m.o.i. 0.2) for 1 h at 377C. Following three washesRuss, Queen Elizabeth Hospital, Adelaide, Australia, and
with PBS, cell monolayers were overlaid with 1.0 ml ofthe DAF mAb 854 was provided by Dr. Philip Minor, Na-
DMEM/1.0% FCS and incubated at 377C for 48 h. Tripli-tional Institute of Biological Standards, Potters Bar, UK.
cate samples containing cells/media were harvested atPhycoerythrin-conjugated goat anti-mouse IgG for FACS-
0, 24, and 48 h postinfection (p.i.) and submitted to threecan analyses was obtained from Boehringer Mannheim
cycles of freeze/thaw, and the infectious CVB1 titer was(Indianapolis, IN). The prototype strain of CVB1 (Conn-5)
determined by plaque assay on HeLa cell monolayers.was provided by M. Kennett, Fairfield Hospital, Victoria;
virus stocks were grown in HEp2 cells to a final titer of Radiolabeled virus binding assay
106.7 TCID50/ml.
CBV1 was radiolabeled in DMEM containing [35S]-
methionine and purified by velocity centrifugation in 5–FACScan analyses
30% sucrose gradients. Gradient-purified [35S]labeled
Monolayer cultures of SW480 and LIM1215 cells were 160 S virus particles were added to confluent monolayers
harvested with 20 mM EDTA and then blocked with goat of cells in 24-well plates at room temperature and al-
serum at 47C for 10 min. Cells were washed once with lowed to adsorb for 1 h. Cells were then washed three
phosphate-buffered saline (PBS) and incubated with pri- times in PBS and lysed in 200 ml of 0.2 M NaOH and 1%
mary antibodies for 20 min at 47C and then washed twice SDS, and the extracts were counted in a liquid scintilla-
with PBS. Cells were then stained with secondary anti- tion counter. Results are expressed as the means of
body conjugated with phycoerythrin for 20 min at 47C, quadruplicate wells plus 2 standard deviations.
washed twice with PBS, and resuspended in 0.5 ml PBS
prior to FACScan analysis (Becton–Dickinson, Ruther- RESULTS
ford, NJ).
Coxsackievirus B1-induced lysis of LIM1215 and
Transfection of SW480 cells SW480 colon cancer cells
In preliminary experiments, we tested the ability ofStably transfected lines of SW480 cells were obtained
as previously described (Weinacker et al., 1994) using CVB1 to induce cytopathic destruction of two DAF-ex-
pressing cell lines, LIM1215 and SW480. At 48 h postin-the expression vector pcDNA1neo b6 which contains the
full-length human b6 gene construct. Modifications of the fection the data in Figs. 1A and 1B indicate that SW480
cells require an approximate input of 105 tissue culturesame vector were used to generate SW480 transfectants
lacking the entire b6 cytoplasmic domain (738t) or lack- infective dose50 (TCID50)/well of CVB1 to produce a de-
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FIG. 1. CVB1-induced cell lysis of SW480 and LIM1215 cells. (A) Cell monolayers were inoculated with CVB1. Following incubation for 48 h at
377C the cell monolayers were inspected for signs of cell lysis and then photographed with Kodak technical Pan 100ASA film. (B). Cell survival
was quantitated as detailed under Materials and Methods. The mean absorbance of triplicate virus-treated wells for each cell line is expressed as
a percentage of the absorbance of control, uninfected wells. (C) Flow cytometric analyses of binding of mAbs 854 (anti-DAF), L230 (anti-av), QE2E5
(anti-b1), AB3 (anti-b3), PIF6 (anti-b5), and E7P6 (anti-b6) to SW480 and LIM1215 cells. Cells were incubated with no primary antibody (white
histograms) or with antibodies as indicated and goat anti-mouse IgG conjugated with phycoerythrin (black histograms).
tectable level of cell lysis. By comparison, LIM1215 cells this source (Fig. 2A); all mock transfectants were nega-
tive for b6 (Fig. 2A). The extent of CVB1-mediated lysisresponded to a 104-fold lower TCID50 input of CVB1 to
produce the same effect. FACScan analyses of both cell at 48 h postinfection for each cell line as a percentage
of that observed for non-viral-treated control cultures islines indicated that in addition to the presence of signifi-
cantly more DAF on LIM1215 cells, there was also a shown in Fig. 2B. At each dilution of virus tested, in-
creased lysis was observed for all b6-expressing linesdifference in the avb6 integrin profile between the two
cell types (Fig. 1C); both cell lines express av, b1, b3, and compared with mock transfectants. SW480 Mock and
b6 transfectants bound similar amounts of 35S-labeledb5; however, LIM1215 cells additionally express avb6.
preparations of CVB1 (Fig. 2C).
Effect of transfection of SW480 cells with b6 cDNA Effect of b6 cytoplasmic domain deletions on lytic
on lytic infection induced by CVB1 infection induced by CVB1
The b6 subunit cytoplasmic domain contains two NPXYTo test the possibility that constitutively expressed
avb6 on LIM1215 cells was responsible, at least in part, motifs and an 11-amino-acid C-terminal extension not found
in other b subunit cytoplasmic domains (Sheppard et al.,for enhanced CVB1-induced cell lysis, the cytopathic ef-
fect of CVB1 was tested on SW480 cells which had been 1990) as shown diagramatically in Fig. 3A. To investigate
whether the cytoplasmic domain of b6 was involved instably transfected with a human b6 gene construct
(Agrez et al., 1994). The stably transfected SW480 parent increased CVB1 cytopathology, stable transfectants of
SW480 b6 containing cytoplasmic b6 deletions were in-b6-expressing cell line and clones obtained from these
cells had levels of surface-expressed DAF similar to fected with CVB1. The SW480 b6 transfectants comprised
full-length b6, a truncated cytoplasmic variant lacking thethose of both parental SW480 cells transfected with vec-
tor alone (mock transfectants) and clones obtained from entire cytoplasmic domain (738t), and a truncated cyto-
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FIG. 2. Stable expression of avb6 results in enhanced lytic infection induced by CVB1. (A) Flow cytometric analyses of binding of mAbs E7P6
(anti-b6) and 854 (anti-DAF) to SW480 mock and SW480 b6 transfectants (parent cell lines and clones C1–C3). The cells were incubated with no
primary antibody (dotted white histograms), with mAb E7P6 (white histograms), or with mAb 854 (black histograms) and with goat anti-mouse IgG
conjugated with phycoerythrin. The avb6 profile SW480 b6(C3) is overlaid by that of the DAF profile. (B) Cell survival. The mean absorbance of
triplicate virus-treated wells for each cell line is expressed as a percentage of the absorbance of control, uninfected cells. (MOCK-PAR, mock
parent; MC1, mock clone 1; MC2, mock clone 2; MC3, mock clone 3; B6-PAR, b6 parent; B6C1, b6 clone 1; B6C2, b6 clone 2; B6C3, b6 clone 3).
(C) Binding assay. Confluent monolayers of SW480 stable transfectants were exposed to purified [35S]methionine-labeled CVB1 (21 104) as described
under Materials and Methods. Results represent the means of quadruplicate wells {2 SD.
plasmic variant which lacked only the C-terminal 11-amino- TCID50 of CVB1 could produce a comparable level of cyto-
pathology in full-length b6-expressing cells; all four cellacid extension (777t) unique to the b6 subunit. In the 777t
truncation variant, the more proximal NPXY motifs were lines bound similar amounts of virus (Fig. 3D).
Viral growth curves of CVB1 in SW480 Mock, SW480retained intact as previously reported (Agrez et al., 1994).
Each of the four transfected SW480 cell lines (mock, full- b6, and SW480 777t cells were performed to confirm that
the increased viral-induced cytopathology in b6-express-length b6, 777t, and 738t) expressed similar amounts of
DAF on the cell surface when stained with anti-DAF mono- ing cells correlated with an increase in infectious viral
titer. The data shown in Fig. 4 indicate that as previouslyclonal antibody, as shown in Fig. 3B. The cell lines trans-
fected with the truncated b6 variants (777t, 738t) expressed observed with the radiolabeled CVB1 binding data (Fig.
2C), all three cell lines bound comparable levels of viruslevels of b6 on the cell surface which were similar to those
of the full-length b6 transfectant (Fig. 3B). Previously we as revealed by the near-identical viral titers at 0 h p.i.
However, at both 24 and 48 h p.i. the b6 cell lysateshave shown that heterologous expression of these mutant
versions of b6, like expression of the full-length receptor, yield approximately a 10-fold greater level of CVB1 than
that observed in SW480 Mock and 777t cell lysates.does not produce systematic alterations in expression of
other integrins (Agrez et al., 1994). The response to CVB1-
mediated lysis as a percentage of non-virus-treated control DISCUSSION
cultures is shown in Fig. 3C; the data indicate that SW480
Mock, 738t, and 777t cells were susceptible to lytic infection Coxsackieviruses are small, nonenveloped, single-
strand RNA enteroviruses belonging to the Picornaviri-at an input of 105 TCID50/well, while approximately 10
2
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FIG. 3. A unique region of the b6 cytoplasmic domain is required for CVB1-induced lytic infection. (A) Schematic representation of the extent of
the cytoplasmic truncations and location of the NPXY motifs. (B) Flow cytometric analyses of binding of mAbs E7P6 (anti-b6) and 854 (anti-DAF) to
SW480 colon cancer cells stably transfected with vector alone (mock parent), the full-length b6 construct (b6 parent), or truncated b6 constructs
lacking the 11-amino-acid C-terminal extension unique to the b6 cytoplasmic domain (777t) or lacking the entire cytoplasmic domain (738t). The
cells were incubated with no primary antibody (dotted white histograms), with mAb E7P6 (white histograms), or with mAb 854 (black histograms)
and with goat anti-mouse IgG conjugated with phycoerythrin. (C) Cell survival. The mean absorbance of triplicate virus-treated wells for each cell
line is expressed as a percentage of the absorbance of control, uninfected wells. (D) Binding of [35S]methionine-labeled CVB1 (2 1 104 cpm) to the
four transfected cell lines. Results represent the means of quadruplicate wells {2 SD.
dae family. One of the major portals of entry of enterovi- man colon cancer cells, expressed either constitutively
or as a consequence of transfection with b6 cDNA, sig-ruses into the body is via the intestine and from this site
of primary replication, enteroviruses spread and target nificantly enhances CVB1-induced cell lysis and virus
production. Moreover, b6-transfected cells were foundthe heart, skeletal muscle, and cells of the immune and
nervous systems. Viremia is not due to a change in viru- to express similar amounts of CAR to mock transfectants
as assessed by FACScan analysis using the monoclonallence of the organism, but to enhanced ability of the
virus to replicate and, thereby, induce cell lysis. We have antibody RmcB (data not shown; antibody provided by
J. M. Bergelson and R. L. Crowell). It is, however, alsorecently reported that the ubiquitous cell membrane mol-
ecule DAF is a major cell attachment receptor for clear that, although the b6 subunit enhances CVB1-medi-
ated lytic infection of colonic epithelial cells, b6 is not anCVB1,CVB3, and CVB5 (Shafren et al., 1995). Given that
DAF is expressed on most mammalian cells including essential cofactor for CVB1 internalization of noncolonic
lines. HeLa cells lack surface expression of b6 (Wei-the intestinal epithelium (Koretz et al., 1992), it is likely
that the cell and tissue tropism of CVB1 is governed nacker et al., 1994) yet are highly susceptible to infection
by Coxsackie Group B viruses (Crowell et al., 1986).by the presence or absence of accessory cell surface
cofactors. For example, a complementary DNA clone that Transfection of susceptible cell lines such as HeLa cells
with b6 cDNA might further enhance the susceptibilityencodes a Coxsackievirus and adenovirus receptor
(CAR) has recently been isolated, and the 46-kDa protein to lytic infection by CVB1.
The mechanisms by which integrins mediate endocy-encoded by CAR cDNA has been shown to mediate both
cell attachment and infection by CVB3 and CVB4 (Bergel- tosis of viruses are not known. It has been suggested
that viral entry into the cytoplasm is contingent uponson et al., 1997; Tomko et al., 1997). In the present study
we report that the presence of the avb6 integrin on hu- localization of viruses to coated pits (White, 1993) and
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internalization. In addition, av integrins are known to play
an important role in cell signaling processes such as
calcium mobilization, protein phosphorylation, cytoskele-
tal interactions, and changes in cytoplasmic pH (Hynes,
1992), any or all of which could alter the level of viral
genome transcription and replication. The effect, how-
ever, appears to be mediated by the 11-amino-acid C-
terminus unique to the b6 subunit. This is the first demon-
stration of regulation of viral infectivity by an integrin
cytoplasmic domain.
What makes avb6 potentially so important is that it is
restricted to epithelial cells such as the intestinal lining
but is either not expressed or expressed at very low
levels on normal cells; however, it becomes highly ex-
pressed during times of morphogenesis, tissue repair,
and tumorigenesis (Breuss et al., 1995). One could postu-FIG. 4. Growth of CVB1 in SW480 Mock, SW480 b6, and SW480 777t
cells. Monolayers of SW480 Mock, SW480 b6, and SW480 777t cells late, therefore, that only when expression of avb6 is
were inoculated with CVB1 (m.o.i. 0.2) and infectious viral titers deter- upregulated secondary to either mucosal injury or inflam-
mined by plaque assay at 0, 24, and 48 h p.i. Results are expressed mation in the intestine does opportunistic overgrowth of
as mean titers for triplicate wells {2 SD.
virus occur with viremic spread to other organs. This
might explain, at least in part, the high incidence of
asymptomatic enteroviral infections in adults.this may involve the cytoplasmic domains of certain inte-
grin subunits. For example, the cytoplasmic domains of
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